CClinicalTrials.gg
Status unknownNCT04033484Updated Feb 8, 2021

Pelvic Floor Reconstruction Using Biological Mesh With Negative Pressure Wound Therapy Following ELAPE

An interventional study of Negative Pressure Wound Therapy in Perineal Wound Complications After ELAPE, sponsored by Beijing Chao Yang Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-02-08.

Sponsored by Beijing Chao Yang Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Perineal wound healing is a significant challenge after extralevator abdominoperineal excision (ELAPE) due to a high rate of wound breakdown. And it was proved that neoadjuvant radiotherapy significantly increases perineal wound problems after abdominoperineal resection for rectal cancer. Negative pressure therapy has proven benefits in open wounds, and recently a negative pressure system has been developed for use on closed wounds at high risk of breakdown. A systematic review suggested a significant decrease in perineal wound complications when using incisional negative pressure wound therapy was demonstrated, with surgical site infection rates as low as 9% (vs 41% in control groups). The review suggested that incisional negative pressure wound therapy decreases perineal wound complications after abdominoperineal resection. Prospective study also suggested that after ELAPE the application of a negative pressure system to the perineal wound closed with biologic mesh may reduce perineal wound complications. The aim of the present study was to determine whether negative pressure therapy combined with biological mesh compared with biological mesh alone after ELAPE could improve wound healing.

02

Conditions studied

  • Perineal Wound Complications After ELAPE

Browse trials for

Keywords

  • extralevator abdominoperineal excision
  • Perineal wound healing
  • negative pressure wound therapy
  • biological mesh
03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.

This study's planned enrollment of 66 is above the median of 52 across 3,239 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Beijing Chao Yang Hospital is the lead sponsor of 135 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Rectal cancer within 4 cm of the anal verge
  2. T3 or T4, as determined by pre-operative MRI examination; patient did receive neoadjuvant chemoradiotherapy
  3. Absence of distant metastases
  4. Absence of intestinal obstruction

Exclusion criteria

Exclusion Criteria:

  1. T1-T2, as determined by pre-operative MRI before neoadjuvant chemoradiotherapy
  2. Distant metastases
  3. Intestinal obstruction
  4. Pregnancy or lactating
  5. Contraindications to surgery
  6. A mental disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Active comparator
    Biological Mesh

    Using biological mesh to recnostruct the pelvic floor following ELAPE

    Procedure: Negative Pressure Wound Therapy

  • Experimental
    Biological Mesh With Negative Pressure Wound Therapy

    Using biological mesh compined with negative pressure wound therapy to recnostruct the pelvic floor following ELAPE

    Procedure: Negative Pressure Wound Therapy

Interventions

  • ProcedureNegative Pressure Wound Therapy

    The perineal wound was reconstructed with biologic mesh after ELAPE. The subcutaneous adipose layer was closed with 2/0 vicryl sutures, and a suction drain was left in the deep layer. The subcuticular layer and skin were closed with 3/0 vicryl mattress sutures and the negative pressure system applied at 80 mmHg

06

What researchers measure

Primary outcomes

  1. perineal wound complications

    perineal wound complications after pelvic floor reconstruction following ELAPE

    Time frame: 6 months after operation

07

Study locations

1 of 1 sites recruiting
  • Zhen Jun. Wang
    Beijing, 100020, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Perineal wound healing is a significant challenge after extralevator abdominoperineal excision (ELAPE) due to a high rate of wound breakdown. And it was proved that neoadjuvant radiotherapy significantly increases perineal wound problems after abdominoperineal resection for rectal cancer. Negative pressure therapy has proven benefits in open wounds, and recently a negative pressure system has been developed for use on closed wounds at high risk of breakdown. Prospective study also suggested that after ELAPE the application of a negative pressure system to the perineal wound closed with biologic mesh may reduce perineal wound complications. The aim of the present study was to determine whether negative pressure therapy combined with biological mesh compared with biological mesh alone after ELAPE could improve wound healing.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04033484
Lead sponsor
Beijing Chao Yang Hospital
Responsible party
Zhen Jun Wang (Chairman of General Surgery, Beijing Chao Yang Hospital) — Principal investigator
First posted
Jul 26, 2019
Start date
Jul 1, 2019
Primary completion
Jul 31, 2021 (estimated)
Completion
Jul 31, 2021 (estimated)
Last update
Feb 8, 2021

Study contacts

Jia Gang Han, MD
Contact
hjg211@163.com
+86013522867841

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion